










Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
NUR 202 Final Review for test 1-2 exam with correct answers
Typology: Exams
1 / 18
This page cannot be seen from the preview
Don't miss anything!
.The |nurse |assesses |a |patient |who |has |numerous |petechiae |on |both |arms. |Which |question |should |the |nurse |ask |the |patient? a. |"Do |you |take |salicylates?" | b. |"Are |you |taking |any |oral |contraceptives?" | c. |"Have |you |been |prescribed |antiseizure |drugs?" | d. |"How |long |have |you |taken |antihypertensive |drugs?" |- |✔✔A The |nurse |assesses |a |patient |with |pernicious |anemia. |Which |assessment |finding |would |the |nurse | expect? a. |Yellow-tinged |sclerae | b. |Shiny, |smooth |tongue | c. |Numbness |of |the |extremities | d. |Gum |bleeding |and |tenderness |- |✔✔C A |patient's |complete |blood |count |(CBC) |shows |a |hemoglobin |of | 19 |g/dL |and |a |hematocrit |of |54%. | Which |question |should |the |nurse |ask |to |determine |possible |causes |of |this |finding? a. |"Have |you |had |a |recent |weight |loss?" | b. |"Do |you |have |any |history |of |lung |disease?" | c. |"Have |you |noticed |any |dark |or |bloody |stools?" | d. |"What |is |your |dietary |intake |of |meats |and |protein?" |- |✔✔B The |nurse |is |reviewing |laboratory |results |and |notes |an |aPTT |level |of | 28 |seconds. |The |nurse |should | notify |the |health |care |provider |in |anticipation |of |adjusting |which |medication? a. |Aspirin |
b. |Heparin | c. |Warfarin | d. |Erythropoietin |- |✔✔B A |patient |with |a |history |of |a |transfusion-related |acute |lung |injury |(TRALI) |is |to |receive |a |transfusion | of |packed |red |blood |cells |(PRBCs). |Which |action |by |the |nurse |will |decrease |the |risk |for |TRALI |for |this | patient? a. |Infuse |the |PRBCs |slowly |over | 4 |hours. | b. |Transfuse |only |leukocyte-reduced |PRBCs. | c. |Administer |the |scheduled |diuretic |before |the |transfusion. | d. |Give |the |PRN |dose |of |antihistamine |before |the |transfusion. |- |✔✔B Which |action |will |the |nurse |include |in |the |plan |of |care |for |a |72-year-old |woman |admitted |with | multiple |myeloma? a. |Monitor |fluid |intake |and |output. | b. |Administer |calcium |supplements. | c. |Assess |lymph |nodes |for |enlargement. | d. |Limit |weight |bearing |and |ambulation. |- |✔✔A A |postoperative |patient |receiving |a |transfusion |of |packed |red |blood |cells |develops |chills, |fever, | headache, |and |anxiety | 35 |minutes |after |the |transfusion |is |started. |After |stopping |the |transfusion, | what |action |should |the |nurse |take? a. |Draw |blood |for |a |new |crossmatch. | b. |Send |a |urine |specimen |to |the |laboratory. | c. |Administer |PRN |acetaminophen |(Tylenol). | d. |Give |the |PRN |diphenhydramine |(Benadryl). |- |✔✔C A |19-year-old |woman |with |immune |thrombocytopenic |purpura |(ITP) |has |an |order |for |a |platelet | transfusion. |Which |information |indicates |that |the |nurse |should |consult |with |the |health |care |provider | before |obtaining |and |administering |platelets? a. |The |platelet |count |is |42,000/mL. |
c. |Increased |suicidal |ideation d. |Presence |of |abdominal |pain |and |diarrhea e. |Hyperactivity |or |feelings |of |restlessness |- |✔✔A |D |E A |tearful, |anxious |patient |at |the |outpatient |clinic |reports, |"I |should |be |dead." |The |initial |task |of |the | nurse |conducting |the |assessment |interview |is |to: a. |assess |the |lethality |of |a |suicide |plan. b. |encourage |expression |of |anger. c. |establish |a |rapport |with |the |patient. d. |determine |risk |factors |for |suicide. |- |✔✔C A |patient |with |mania |relapsed |after |discontinuing |lithium. |New |orders |are |written |to |resume |lithium | twice |daily |and |begin |olanzapine |(Zyprexa). |The |addition |of |olanzapine |to |the |medication |regimen | will: a. |minimize |the |side |effects |of |lithium. b. |bring |hyperactivity |under |rapid |control. c. |enhance |the |antimanic |actions |of |lithium. d. |be |used |for |long-term |control |of |hyperactivity. |- |✔✔B A |patient |with |bipolar |disorder |has |rapid |cycles. |The |health |care |provider |prescribes |an | anticonvulsant |medication. |To |prepare |teaching |materials, |which |drug |should |the |nurse |anticipate |will |be |prescribed? a. |phenytoin |(Dilantin) b. |clonidine |(Catapres) c. |carbamazepine |(Tegretol) d. |chlorpromazine |(Thorazine) |- |✔✔C
a. |Neurobiological b. |Developmental c. |Family |theory d. |Genetic e. |Stress |- |✔✔A |D Ten |days |after |receiving |a |bone |marrow |transplant, |a |patient |develops |a |skin |rash. |What |would |the | nurse |suspect |is |the |cause |of |this |patient's |skin |rash? a. |The |donor |T |cells |are |attacking |the |patient's |skin |cells. | b. |The |patient's |antibodies |are |rejecting |the |donor |bone |marrow. | c. |The |patient |is |experiencing |a |delayed |hypersensitivity |reaction. | d. |The |patient |will |need |treatment |to |prevent |hyperacute |rejection. |- |✔✔A An |older |adult |patient |has |a |prescription |for |cyclosporine |following |a |kidney |transplant. |Which | information |in |the |patient's |health |history |has |the |most |implications |for |planning |patient |teaching | about |the |medication |at |this |time? a. |The |patient |restricts |salt |to |treat |prehypertension. | b. |The |patient |drinks | 3 |to | 4 |quarts |of |fluids |every |day. | c. |The |patient |has |many |concerns |about |the |effects |of |cyclosporine. | d. |The |patient |has |a |glass |of |grapefruit |juice |every |day |for |breakfast. |- |✔✔D A |patient |is |admitted |to |the |hospital |with |acute |rejection |of |a |kidney |transplant. |Which |intervention | will |the |nurse |prepare |for |this |patient? a. |Administration |of |immunosuppressant |medications | b. |Insertion |of |an |arteriovenous |graft |for |hemodialysis | c. |Placement |of |the |patient |on |the |transplant |waiting |list | d. |A |blood |draw |for |human |leukocyte |antigen |(HLA) |matching |- |✔✔A A |patient |who |has |received |allergen |testing |using |the |cutaneous |scratch |method |has |developed | itching |and |swelling |at |the |skin |site. |Which |action |should |the |nurse |take |first?
a. |Administer |epinephrine. | b. |Apply |topical |hydrocortisone. | c. |Monitor |the |patient |for |lower |extremity |edema. | d. |Ask |the |patient |about |exposure |to |any |new |lotions |or |soaps. |- |✔✔A Immediately |after |the |nurse |administers |an |intracutaneous |injection |of |an |allergen |on |the |forearm, |a | patient |complains |of |itching |at |the |site |and |of |weakness |and |dizziness. |What |action |should |the |nurse | take |first? a. |Remind |the |patient |to |remain |calm. | b. |Administer |subcutaneous |epinephrine. | c. |Apply |a |tourniquet |above |the |injection |site. | d. |Rub |a |local |antiinflammatory |cream |on |the |site. |- |✔✔C A |nurse |has |obtained |donor |tissue |typing |information |about |a |patient |who |is |waiting |for |a |kidney | transplant. |Which |results |should |be |reported |to |the |transplant |surgeon? a. |Patient |is |Rh |positive |and |donor |is |Rh |negative | b. |Six |antigen |matches |are |present |in |HLA |typing | c. |Results |of |patient-donor |cross |matching |are |positive | d. |Panel |of |reactive |antibodies |(PRA) |percentage |is |low |- |✔✔C A |patient |who |is |receiving |immunotherapy |has |just |received |an |allergen |injection. |Which |assessment | finding |is |most |important |to |communicate |to |the |health |care |provider? a. |The |patient's |IgG |level |is |increased. | b. |The |injection |site |is |red |and |swollen. | c. |The |patient's |allergy |symptoms |have |not |improved. | d. |There |is |a |2-cm |wheal |at |the |site |of |the |allergen |injection. |- |✔✔D A |patient |who |has |vague |symptoms |of |fatigue, |headaches, |and |a |positive |test |for |human | immunodeficiency |virus |(HIV) |antibodies |using |an |enzyme |immunoassay |(EIA) |test. |What |instructions | should |the |nurse |give |to |this |patient? a. |"The |EIA |test |will |need |to |be |repeated |to |verify |the |results." |
a. |The |patient |will |be |free |from |injury. | b. |The |patient |will |receive |immunizations. | c. |The |patient |will |have |adequate |oxygenation. | d. |The |patient |will |maintain |intact |perineal |skin. |- |✔✔D The |nurse |prepares |to |administer |the |following |medications |to |a |hospitalized |patient |with |human | immunodeficiency |(HIV). |Which |medication |is |most |important |to |administer |at |the |right |time? a. |Oral |acyclovir |(Zovirax) | b. |Oral |saquinavir |(Invirase) | c. |Nystatin |(Mycostatin) |tablet | d. |Aerosolized |pentamidine |(NebuPent) |- |✔✔B An |older |adult |who |takes |medications |for |coronary |artery |disease |has |just |been |diagnosed |with | asymptomatic |chronic |human |immunodeficiency |virus |(HIV) |infection. |Which |information |will |the | nurse |include |in |patient |teaching? a. |Many |medications |have |interactions |with |antiretroviral |drugs. | b. |Less |frequent |CD4+ |level |monitoring |is |needed |in |older |adults. | c. |Hospice |care |is |available |for |patients |with |terminal |HIV |infection. | d. |Progression |of |HIV |infection |occurs |more |rapidly |in |older |patients. |- |✔✔A The |nurse |cares |for |a |patient |infected |with |human |immunodeficiency |virus |(HIV) |who |has |just |been | diagnosed |with |asymptomatic |chronic |HIV |infection. |Which |prophylactic |measures |will |the |nurse | include |in |the |plan |of |care |(select |all |that |apply)? a. |Hepatitis |B |vaccine | b. |Pneumococcal |vaccine | c. |Influenza |virus |vaccine | d. |Trimethoprim-sulfamethoxazole | e. |Varicella |zoster |immune |globulin |- |✔✔A |B |C The |health |care |provider |has |prescribed |the |following |collaborative |interventions |for |a |patient |who |is | taking |azathioprine |(Imuran) |for |systemic |lupus |erythematosus. |Which |order |will |the |nurse |question?
a. |Draw |anti-DNA |blood |titer. | b. |Administer |varicella |vaccine. | c. |Naproxen |(Aleve) | 200 |mg |BID. | d. |Famotidine |(Pepcid) | 20 |mg |daily. |- |✔✔B In |teaching |a |patient |with |SLE |about |the |disorder, |the |nurse |knows |that |the |pathophysiology |of |SLE | includes a. |circulating |immune |complexes |formed |from |IgG |autoantibodies |reacting |with |IgG b. |an |autoimmune |T-cell |reaction |that |results |in |destruction |of |the |deep |dermal |skin |layer c. |immunologic |dysfunction |leading |to |chronic |inflammation |in |the |cartilage |and |muscles d. |the |production |of |a |variety |of |autoantibodies |directed |against |components |of |the |cell |nucleus |- | ✔✔D The |pathophysiology |of |systemic |lupus |erthematosus |(SLE) |is |characterized |by a. |destruction |of |nucleic |acids |and |other |self-proteins |by |autoantibodies b. |overproduction |of |collagen |that |disrupts |the |functioning |of |internal |organs c. |formation |of |abnormal |IgG |that |attaches |to |cellular |antigens, |activating |complement d. |increased |activity |of |T-suppressor |cells |with |B-cell |hypoactivity, |resulting |in |an |immunodeficiency |- | ✔✔A A |patient |with |newly |diagnosed |SLE |asks |the |nurse |how |the |disease |will |affect |her |life. |The |best | response |by |the |nurse |is a. |You |can |plan |to |have |a |near-normal |life |since |SLE |rarely |causes |death b. |it |is |difficult |to |tell |because |to |disease |is |so |variable |in |its |severity |and |progression c. |life |span |is |shortened |somewhat |in |people |with |SLE, |but |the |disease |can |be |controlled |with |long- term |use |of |corticosteroids d. |most |people |with |SLE |have |alternating |periods |of |remissions |and |exacerbations |with |rapid | progression |to |permanent |organ |damage |- |✔✔B During |an |acute |exacerbation, |a |patient |with |SLE |is |treated |with |corticosteroids. |The |nurse |would | expect |the |steroids |to |begin |to |be |tapered |when |serum |laboratory |results |indicate a. |increased |RBCs b. |decreased |ESR c. |decreased |anti-DNA d. |increased |complement |- |✔✔C
c. |Pinpoint |pupils |and |respiratory |rate |of | 12 |breaths |per |minute d. |Confusion, |mouth |ulcers, |and |ataxia |- |✔✔D
B. |Neuroleptic |malignant |syndrome |and |treat |by |increasing |Thorazine |dosage |and |administering |an | antianxiety |medication C. |Dystonia |and |treat |by |administering |trihexyphenidyl |(Artane) D. |Dystonia |and |treat |by |administering |bromocriptine |(Parlodel) |- |✔✔A A |client |has |been |recently |admitted |to |an |inpatient |psychiatric |unit. |Which |intervention |should |the | nurse |plan |to |use |to |reduce |the |client's |focus |on |delusional |thinking? A. |Present |evidence |that |supports |the |reality |of |the |situation B. |Focus |on |feelings |suggested |by |the |delusion C. |Address |the |delusion |with |logical |explanations D. |Explore |reasons |why |the |client |has |the |delusion |- |✔✔B A |nurse |is |administering |risperidone |(Risperdal) |to |a |client |diagnosed |with |schizophrenia. |The | therapeutic |effect |of |this |medication |would |most |effectively |address |which |of |the |following | symptoms? |(Select |all |that |apply.) A. |Somatic |delusions B. |Social |isolation C. |Gustatory |hallucinations D. |Flat |affect E. |Clang |associations |- |✔✔A |C |E The |most |common |type |of |leukemia |in |older |adults |is | a. |acute |myelocytic |leukemia. b. |acute |lymphocytic |leukemia. c. |chronic |myelocytic |leukemia. d. |chronic |lymphocytic |leukemia. |- |✔✔D The |nurse |is |aware |that |a |major |difference |between |Hodgkin's |lymphoma |and |non-Hodgkin's | lymphoma |is |that a. |Hodgkin's |lymphoma |occurs |only |in |young |adults. b. |Hodgkin's |lymphoma |is |considered |potentially |curable. c. |non-Hodgkin's |lymphoma |can |manifest |in |multiple |organs.